Loading clinical trials...
Loading clinical trials...
Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie
Can MRI be used to stage ovarian cancer?
Staging of ovarian cancer can best be performed with CT or MRI compared to ultrasound. Studies have shown an increase in pos. predictive value by adding contrast i.v. to the MR-examination protocol. We compare staging of ovarian cancer by 1.MRI without contrast (standard method) to 2.MRI with contrast agent i.v. (new method)in the same patient. Golden standard are findings at operation.
Age
All ages
Sex
FEMALE
Healthy Volunteers
No
Start Date
April 1, 2007
Completion Date
April 1, 2008
Last Updated
April 20, 2007
50
Estimated participants
Lead Sponsor
University of Aarhus
NCT05039801
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions